SeekIn Inc, a pacesetter in blood-based most cancers early detection and monitoring expertise, introduced a strategic collaboration with Oncolnv, a fully-owned affiliate of Inspire2Live, to develop the worldwide accessibility of their a number of most cancers detection checks and bridge disparities in most cancers care.
Beginning this December, SeekIn’s complete vary of most cancers detection checks, particularly OncoSeek, SeekInCare, SeekInCure and SeekInClarity will probably be distributed by Oncolnv within the following twelve nations: Belgium, Bulgaria, Costa Rica, Egypt, Ghana, Kenya, the Netherlands, Nigeria, Qatar, Singapore, Tanzania and UAE.
The settlement was formalized throughout the 2023 Inspire2Live Annual Congress held on November 29th and 30th in Amsterdam, the Netherlands. Representatives from 27 nations who’re dedicated to bringing the affected person voice to the desk joined this yr’s congress on the theme of “If about us, not with out us”. SeekIn’s founder and CEO, Dr. Mao Mao, delivered an inspiring speech, shedding gentle on the corporate’s cutting-edge most cancers detection checks, whereas emphasizing the significance of early detection and improved affected person outcomes. The OncoSeek take a look at focuses on screening 9 widespread most cancers varieties with seven protein tumor markers (PTMs) whereas SeekInCare, SeekInCure and SeekInClarity are designed for most cancers early detection, recurrence monitoring and remedy monitoring respectively incorporating shallow complete genomic sequencing and PTMs. Contributors on the Inspire2Live congress got the chance to take an OncoSeek take a look at.
Commenting on the importance of this collaboration, Dr. Mao Mao acknowledged, “We’re thrilled to affix forces with Inspire2Live and Oncolnv, two patient-centric organizations dedicated to revolutionizing most cancers detection and remedy. With their intensive community and dedication to the trigger, we are able to higher serve most cancers sufferers globally, offering them with superior detection applied sciences and empowering healthcare suppliers with the instruments that they should battle this devastating illness.”
Inspire2Live’s founder, Mr. Peter Kapitein, expressed his pleasure concerning the partnership, stating, “This collaboration aligns completely with our group’s imaginative and prescient of a world the place entry to high quality most cancers care is common. Collectively, we are able to make an actual distinction within the lives of numerous sufferers across the globe.” Oncolnv is on the forefront of scientific settings and pays appreciable consideration to most cancers screening, early prognosis and personalised monitoring with affected person care on the core. By partnering with SeekIn, Oncolnv good points priceless entry to complete most cancers detection options for numerous well being care techniques, serving to to bridge world disparities in most cancers care.
As well as, this collaboration opens doorways to future analysis initiatives, creating alternatives for joint scientific trials, data change, and collaborative growth of progressive most cancers detection methodologies. By leveraging the experience of each organizations, this collaborative effort goals to enhance affected person outcomes and improve survival charges.
As SeekIn expands its world footprint, its dedication to analysis, innovation, and patient-centric care stays unwavering. The collaboration between SeekIn and Oncolnv brings collectively the collective experience and sources wanted to handle the worldwide most cancers burden comprehensively.